ArticleCureus2022

Real-World Clinical Experience of Rosuvastatin as a Lipid-Lowering Therapy for Primary and Secondary Prevention of Cardiovascular Events (REAL ROSE).

Ashwani Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.